Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSLT
2376
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $794K | ﹤0.01% |
160,404
+60,928
| +61% | +$276K |
|
2377
iShares US Medical Devices ETF
IHI
$3.42B
| $793K | ﹤0.01% |
+35,730
| New | +$811K |
|
2378
Omeros
OMER
$1.32B
| $793K | ﹤0.01% |
+79,962
| New | +$816K |
|
2379
RadNet
RDNT
$6.02B
| $790K | ﹤0.01% |
122,404
+101,003
| +472% | +$682K |
|
2380
Agnico Eagle Mines
AEM
$108B
| $789K | ﹤0.01% |
18,788
+4,472
| +31% | +$198K |
|
2381
Cato Corp
CATO
$55.3M
| $786K | ﹤0.01% |
+26,141
| New | +$804K |
|
|
RC
2382
Ready Capital
RC
$304M
| $783K | ﹤0.01% |
+58,210
| New | +$786K |
|
2383
BlackRock Debt Strategies Fund
DSU
$592M
| $779K | ﹤0.01% |
68,660
+57,536
| +517% | +$629K |
|
|
SWIR
2384
DELISTED
Sierra Wireless
SWIR
| $779K | ﹤0.01% |
49,593
-5,107
| -9% | -$76.1K |
|
|
MDLY
2385
DELISTED
Medley Management Inc
MDLY
| $778K | ﹤0.01% |
+7,857
| New | +$724K |
|
2386
Park National Corp
PRK
$3.6B
| $775K | ﹤0.01% |
6,480
+2,807
| +76% | +$300K |
|
|
PKD
2387
DELISTED
Parker Drilling Company
PKD
| $775K | ﹤0.01% |
19,871
+8,671
| +77% | +$296K |
|
2388
Invesco Financial Preferred ETF
PGF
$661M
| $774K | ﹤0.01% |
43,080
-29,037
| -40% | -$533K |
|
|
ZGNX
2389
DELISTED
Zogenix, Inc.
ZGNX
| $774K | ﹤0.01% |
+63,711
| New | +$700K |
|
2390
Geron
GERN
$983M
| $772K | ﹤0.01% |
372,819
+307,899
| +474% | +$650K |
|
2391
iShares MSCI Turkey ETF
TUR
$223M
| $772K | ﹤0.01% |
23,762
-205,136
| -90% | -$7.1M |
|
|
AFH
2392
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $771K | ﹤0.01% |
+42,726
| New | +$727K |
|
2393
American Eagle Outfitters
AEO
$2.95B
| $770K | ﹤0.01% |
50,770
-229,673
| -82% | -$3.93M |
|
2394
Compañía de Minas Buenaventura
BVN
$9.19B
| $770K | ﹤0.01% |
68,257
-48,642
| -42% | -$581K |
|
|
KDMN
2395
DELISTED
Kadmon Holdings, Inc.
KDMN
| $768K | ﹤0.01% |
143,550
-119,339
| -45% | -$671K |
|
2396
Accuray
ARAY
$31.6M
| $767K | ﹤0.01% |
166,659
-1,051,836
| -86% | -$5.46M |
|
|
MRTX
2397
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $766K | ﹤0.01% |
161,305
+85,004
| +111% | +$462K |
|
2398
Nuveen Preferred & Income Opportunities Fund
JPC
$2.81B
| $764K | ﹤0.01% |
77,656
+67,419
| +659% | +$646K |
|
2399
Alpha and Omega Semiconductor
AOSL
$793M
| $763K | ﹤0.01% |
35,862
-6,606
| -16% | -$143K |
|
2400
iShares Biotechnology ETF
IBB
$10.8B
| $763K | ﹤0.01% |
8,625
-39,102
| -82% | -$3.56M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.